What is intellectual asset management?

The patent portfolio is the most visible asset class and usually the smallest. A working IAM inventory also covers trade secrets (formulas, source code, manufacturing parameters, supplier terms, customer analytics), the know-how in engineers' heads that has never been written down, invention disclosures that were documented but never filed, proprietary data sets, defensive publications, and brands. Each class carries value differently and calls for different handling.

Most of it is invisible until someone goes looking. In our facilitated extraction sessions we routinely surface what we call lost IP: inventions the company is already shipping, trade secrets it is already relying on, and disclosure candidates nobody wrote up. In a modern company, most intellectual asset value never gets written down, which means it cannot be protected, valued, or retained when the person who holds it leaves.

Patent portfolio management is one IAM practice among several. It manages the assets a company already chose to file: prosecution status, renewal decisions, claim coverage against products. IAM sits a level up. It covers the asset classes that never enter the docket, and it owns the choice itself: for each asset, protect it with a filing, keep it secret, publish it defensively, or let it go.

IAM also connects IP to the rest of the business in a way docket management cannot. Idea extraction, patent review committees, valuations, trade secret programs, and the link between IP and R&D planning are all IAM practices. Without them, IP defaults to a familiar pattern: the company files whatever surfaces organically, through external counsel, and calls the result a strategy. In our experience across more than 2,000 engagements, very few companies have a documented IP strategy, and fewer still manage anything beyond the patent docket.

IAM runs as a loop, not a project. Inventory first: catalog the patents and applications, then the harder part, trade secrets and know-how, which usually takes structured interviews because nobody self-reports. Classify and map second: tie each asset to the products, revenue lines, and markets it touches, so its value has an address. Decide third: protect, publish, keep secret, or abandon, asset by asset, against consistent criteria.

Fourth, align spending with value. Renewal fees compound across jurisdictions, and pruning is where an inventory pays for itself. In one portfolio review, half of a roughly 200-patent portfolio no longer had evidence of use because the products had evolved away from the claims; the owner was paying maintenance fees on assets no longer doing their job. Fifth, review on a cadence: a full pass annually, renewals on their statutory deadlines, and a look at competitor filings every six to twelve months.

The pattern we encounter most often is a competently managed docket and nothing else under management. Renewals get paid on time while trade secrets go unlisted, know-how walks out with departing employees, and inventions ship unprotected because nobody harvested them. The docket is the one asset class with a built-in calendar and outside counsel attached, so it gets managed by default while the larger share of value gets managed by accident.

Good IAM is legible to leadership. It looks like a living inventory rather than a one-time audit, written decision criteria for each asset class, and a short set of KPIs a board can read: how much revenue is covered by protected assets, how many disclosures came in this quarter, and renewal spend against assessed value. None of it requires a large team. It requires deciding that the assets are worth managing.